Tuesday, 02 January 2024 12:17 GMT

Fertility Tourism Market Analysis And Forecast 2025-2030: Key Technologies And Strategies Redefining Reproductive Care Globally


(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The "Fertility Tourism Market by Treatment Type (Egg Donation, ICSI, IVF), Patient Type (Heterosexual Couples, Same Sex Couples, Single Men), Cycle Type, Provider Type, Payment Mode - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.

Fertility tourism is redefining how individuals and couples access advanced reproductive care, offering expanded choices where local options are limited or less comprehensive. Market forces, cross-border collaboration, and evolving patient demand continue to shape this sector's growth trajectory and service offerings.

Market Snapshot: Fertility Tourism Market Size and Growth

The fertility tourism market grew from USD 463.18 million in 2024 to USD 514.15 million in 2025 and is projected to reach USD 843.21 million by 2030, expanding at a CAGR of 10.50%. This robust momentum reflects strong global demand for reproductive services, cross-border care solutions, and innovations in treatment delivery that are enhancing both patient experience and provider competitiveness.

Scope & Segmentation of the Fertility Tourism Market

This comprehensive report examines the global fertility tourism industry across multiple dimensions, providing actionable insights tailored for senior decision-makers in healthcare, investment, and regulatory spheres.

  • Treatment Types: Egg donation (fresh and frozen donor egg), ICSI, IVF (conventional IVF, IMSI), sperm donation (fresh and frozen), surrogacy (gestational, traditional).
  • Patient Types: Heterosexual couples, same sex couples, single men, single women.
  • Cycle Types: Fresh cycle, frozen cycle (cryopreservation, thawed transfer).
  • Provider Types: Diagnostic laboratories, fertility clinics, hospitals.
  • Payment Modes: Financing, insurance, out-of-pocket.
  • Regional Coverage: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including U.K., Germany, France, Middle Eastern and African key markets), Asia-Pacific (China, India, Japan, Australia, Southeast Asian countries).
  • Technologies: Intracytoplasmic sperm injection, in vitro fertilization enhancements, genetic screening capabilities, digital engagement platforms, telemedicine, artificial intelligence, predictive analytics for protocol optimization.

Key Takeaways for Fertility Tourism Market Stakeholders

  • Rapid advances in treatment modalities and diagnostics are aligning with patient expectations for personalized care and higher efficacy.
  • Regulatory variations and evolving legal frameworks in key regions require providers to implement robust compliance and patient navigation strategies.
  • Integrated service models, including psychological support and genetic counseling, are increasingly viewed as differentiation levers to deepen patient trust.
  • Strategic partnerships between clinics, diagnostic laboratories, and biotechnology innovators are accelerating adoption of cutting-edge reproductive technologies.
  • Providers are responding to diverse social, legal, and financial needs across patient types, expanding beyond traditional couples to serve single individuals and same-sex couples.
  • Regional nuances are critical; providers must tailor engagement, pricing, and service portfolios to local cultural and regulatory realities.

Tariff Impact: U.S. 2025 Measures

The introduction of 2025 U.S. tariffs on selected fertility treatment components has led to increased costs for imported materials, directly influencing operational expenses and global sourcing strategies. Providers are partnering with international manufacturers to counter supply chain disruptions, while patients actively compare tariff-adjusted prices online to secure cost-effective, high-quality treatment options. The evolving tariff environment has intensified the need for transparent pricing and flexible reimbursement models.

Methodology & Data Sources

This report is grounded in a multimodal research approach. Primary qualitative interviews with fertility specialists and patient advocates provide front-line insights into evolving care models. Secondary data sources include peer-reviewed journals and industry policy reviews. Quantitative surveys and data validation ensure trend accuracy and regional relevance.

Why This Fertility Tourism Report Matters

  • Empowers leaders to benchmark operations against emerging global best practices in fertility care and patient engagement.
  • Equips decision-makers with actionable market intelligence for investment planning, risk mitigation, and service portfolio development.
  • Supports proactive strategy development by highlighting policy, regional, and technological shifts shaping global reproductive healthcare access.

Key Attributes

Report Attribute Details
No. of Pages 182
Forecast Period 2025-2030
Estimated Market Value (USD) in 2025 $514.15 Million
Forecasted Market Value (USD) by 2030 $843.21 Million
Compound Annual Growth Rate 10.5%
Regions Covered Global

Key Topics Covered
1. Preface
2. Research Methodology
3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased demand for double embryo transfers driven by cost and success rates
5.2. Surge in patient preference for bundled IVF packages with legal and travel assistance services
5.3. Adoption of AI-driven embryo selection tools in fertility tourism destinations bridging patient demand and success rates
5.4. Growth in cross-border surrogacy arrangements in countries with emerging regulatory frameworks
5.5. Rising popularity of fertility tourism packages integrating genetic screening and personalized treatment plans
5.6. Expansion of fertility tourism marketing targeting millennial and Gen Z patients through social media influencers
5.7. Impact of restrictive legislation in home countries driving infertile couples to seek international IVF services
5.8. Adoption of telemedicine consultations reducing pretravel barriers and improving patient engagement for overseas IVF
6. Market Insights
6.1. Porter's Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025

8. Fertility Tourism Market, by Treatment Type
8.1. Introduction
8.2. Egg Donation
8.2.1. Fresh Donor Egg
8.2.2. Frozen Donor Egg
8.3. ICSI
8.4. IVF
8.4.1. Conventional IVF
8.4.2. IMSI
8.5. Sperm Donation
8.5.1. Fresh Donor Sperm
8.5.2. Frozen Donor Sperm
8.6. Surrogacy
8.6.1. Gestational Surrogacy
8.6.2. Traditional Surrogacy
9. Fertility Tourism Market, by Patient Type
9.1. Introduction
9.2. Heterosexual Couples
9.3. Same Sex Couples
9.4. Single Men
9.5. Single Women
10. Fertility Tourism Market, by Cycle Type
10.1. Introduction
10.2. Fresh Cycle
10.3. Frozen Cycle
10.3.1. Cryopreservation
10.3.2. Thawed Transfer
11. Fertility Tourism Market, by Provider Type
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Fertility Clinics
11.4. Hospitals
12. Fertility Tourism Market, by Payment Mode
12.1. Introduction
12.2. Financing
12.3. Insurance
12.4. Out Of Pocket
13. Americas Fertility Tourism Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Fertility Tourism Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Fertility Tourism Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis

The companies profiled in this Fertility Tourism market report include:

  • IVI-RMA Global, S.L.
  • Virtus Health Limited
  • Monash IVF Group Limited
  • CCRM Fertility (Canada) Inc.
  • Bourn Hall International Limited
  • RMA Network, Inc.
  • CARE Fertility Group Limited
  • Nova IVF Fertility Limited
  • Indira IVF Limited
  • Reprofit International s.r.o.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Fertility Tourism Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN20082025004107003653ID1109952346

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search